PMCB logo

PharmaCyte Biotech, Inc. (PMCB)

Profile

Full Name

PharmaCyte Biotech, Inc.

Ticker

NASDAQ: PMCB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 2, 2013

Indexes

Not included

Website

http://pharmacyte.com

Employees

2

Key Details

Price

$1.02(+6.81%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.80(-718.18% YoY)

PE ratio

1.38

Next earnings date

Sep 17, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.02
    PMCB price is $1.02

    30-Day Relative Volume

    1.18
    PMCB 30-day relative volume is 1.18

    Price Performance

    Price Today change

    +6.81%
    PMCB price is up +6.81% today

    Price YTD change

    -35.03%
    PMCB price is down -35.03% since January 1st

    Price 1-year change

    -48.51%
    PMCB price is down -48.51% year-on-year

    Price 3-year change

    -57.32%
    PMCB price is down -57.32% over the past 3 years

    Price Range

    Price All-time high

    $961.00
    PMCB price is currently -99.89% below its historical high of $961.00

    Price 3-year low

    $0.95
    PMCB price is currently +7.37% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $7.00M
    PMCB market capitalization is $7.00 million

    Market cap 3-year change

    -85.88%
    PMCB market capitalization is down -85.88% over the past 3 years

    Market cap All-time high

    $317.94M
    PMCB market capitalization is currently -97.80% below its historical high of $317.94 million

    Market cap sector rank

    13.03%
    PMCB market capitalization is higher than 13.03% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -11.14%
    PMCB shares outstanding is down -11.14% year-on-year

    Shares Outstanding 3-Year Change

    -68.23%
    PMCB shares outstanding is down -68.23% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.51
    PMCB beta is 0.51

    200-day SMA

    $1.44
    PMCB price is currently -29.35% below its 200-day simple moving average

    50-day SMA

    $1.05
    PMCB price is currently -3.23% below its 50-day simple moving average

    RSI

    33.80
    PMCB 14-day relative strength index is 33.80

    Volume

    1.18
    PMCB 30-day relative volume is 1.18

    ATR

    $0.07
    PMCB average true range is $0.07

    10-day Historical Volatility

    51.39%
    PMCB 10-day historical volatility is 51.39%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    PMCB annual revenue value is unknown

    Revenue Analysts estimate

    -
    PMCB annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    PMCB annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    PMCB annual revenue is unknown

    EPS

    EPS

    -$1.80
    PMCB annual earnings per share is -$1.80

    EPS Analysts estimate

    -
    PMCB annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -718.18%
    PMCB annual earnings per share is down -718.18% year-on-year

    EPS Sector rank

    41.33%
    PMCB annual earnings per share is higher than 41.33% of companies in Healthcare sector

    Profit

    Gross profit

    -
    PMCB annual gross profit value is unknown

    Gross margin

    -
    PMCB annual gross profit margin value is unknown

    Operating profit

    -$6.52M
    PMCB annual operating income is -$6.52 million

    Operating margin

    -
    PMCB annual operating profit margin value is unknown

    Net income

    $333.80K
    PMCB annual net profit is $333.80 thousand

    Net margin

    -
    PMCB annual net profit margin value is unknown

    Expenses

    Total expenses

    $6.52M
    PMCB annual total expenses is $6.52 million

    Operating expenses

    $6.52M
    PMCB annual total operating expenses is $6.52 million

    Cost of goods sold

    -
    PMCB annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $4.79M
    PMCB annual SGA is $4.79 million

    Depreciation and amortization

    -
    PMCB annual depreciation & amortization value is unknown

    Interest expense

    -
    PMCB annual interest expense value is unknown

    Income tax

    -
    PMCB annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$6.52M
    PMCB annual earnings before interest & taxes is -$6.52 million

    EBITDA

    -$6.52M
    PMCB annual EBITDA is -$6.52 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $59.90M
    PMCB annual total assets is $59.90 million

    Non current assets

    $9.46M
    PMCB annual long term assets is $9.46 million

    Current assets

    $50.44M
    PMCB annual total current assets is $50.44 million

    Cash and cash equivalents

    $50.18M
    PMCB annual cash & cash equivalents is $50.18 million

    Accounts receivable

    -
    PMCB annual accounts receivable value is unknown

    Inventory

    -
    PMCB annual inventory value is unknown

    Liabilities

    Total liabilities

    $20.39M
    PMCB annual total liabilities is $20.39 million

    Long term liabilities

    $12.97M
    PMCB annual total long term liabilities is $12.97 million

    Current liabilities

    $7.42M
    PMCB annual total current liabilities is $7.42 million

    Accounts payable

    $389.40K
    PMCB annual accounts payable is $389.40 thousand

    Debt

    Total debt

    $0.00
    PMCB annual total debt is $0.00

    Total debt 1-year change

    0%
    PMCB annual total debt has remained unchanged year-on-year

    Long term debt

    -
    PMCB annual long term debt value is unknown

    Short term debt

    -
    PMCB annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $39.51M
    PMCB annual stockholders equity is $39.51 million

    Book value

    $27.65M
    PMCB annual book value is $27.65 million

    Retained earnings

    -$115.63M
    PMCB annual retained earnings is -$115.63 million

    Working capital

    $43.02M
    PMCB annual working capital is $43.02 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$2.15M
    PMCB annual cash flow from operations is -$2.15 million

    Cash from operations 1-year change

    +43.29%
    PMCB annual cash flow from operations is up +43.29% year-on-year

    Cash from investing

    -$5.00M
    PMCB annual cash flow from investing activities is -$5.00 million

    Cash from investing 1-year change

    -100%
    PMCB annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    -$10.71M
    PMCB annual cash flow from financing activities is -$10.71 million

    Cash from financing 1-year change

    +21.03%
    PMCB annual cash flow from financing activities is up +21.03% year-on-year

    CAPEX

    CAPEX

    -
    PMCB annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    PMCB annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$2.15M
    PMCB annual free cash flow is -$2.15 million

    Free cash flow 1-year change

    +43.29%
    PMCB annual free cash flow is up +43.29% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    PMCB annual gross profit margin value is unknown

    Operating margin

    -
    PMCB annual operating profit margin value is unknown

    Net margin

    -
    PMCB annual net profit margin value is unknown

    ROA & ROE

    ROA

    0.56%
    PMCB annual return on assets is 0.56%

    ROE

    0.84%
    PMCB annual return on equity is 0.84%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    1.38
    PMCB price to earnings ratio is 1.38

    PE ratio Sector rank

    2.36%
    PMCB price to earnings ratio is higher than 2.36% of companies in Healthcare sector

    PB Ratio

    PB ratio

    0.17
    PMCB price to book ratio is 0.17

    PB ratio Sector rank

    18.11%
    PMCB price to book ratio is higher than 18.11% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    PMCB price to sales ratio value is unknown

    PS ratio Sector rank

    -
    PMCB price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$9.38M
    PMCB enterprise value is -$9.38 million

    Enterprise value Sector rank

    3.25%
    PMCB enterprise value is higher than 3.25% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    2.08
    PMCB EV/EBITDA is 2.08

    EV/EBITDA Sector rank

    76.5%
    PMCB EV/EBITDA is higher than 76.5% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    6.80
    PMCB annual current ratio is 6.80

    Quick ratio

    -
    PMCB annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    PMCB annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    PMCB annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    PMCB piotroski f-score value is unknown

    Altman Z-Score

    -
    PMCB altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Nov 8, 21 HC Wainwright & Co.
    Neutral

    Institutional Ownership

    Screeners with PMCB included

    US stocks
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Stocks with low PE ratio
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Companies with buyback
    Biotech Companies
    • What is the ticker symbol for PharmaCyte Biotech, Inc.?
    • Does PharmaCyte Biotech, Inc. pay dividends?
    • What sector is PharmaCyte Biotech, Inc. in?
    • What industry is PharmaCyte Biotech, Inc. in?
    • What country is PharmaCyte Biotech, Inc. based in?
    • When did PharmaCyte Biotech, Inc. go public?
    • Is PharmaCyte Biotech, Inc. in the S&P 500?
    • Is PharmaCyte Biotech, Inc. in the NASDAQ 100?
    • Is PharmaCyte Biotech, Inc. in the Dow Jones?
    • When was PharmaCyte Biotech, Inc.'s last earnings report?
    • When does PharmaCyte Biotech, Inc. report earnings?

    What is the ticker symbol for PharmaCyte Biotech, Inc.?

    The ticker symbol for PharmaCyte Biotech, Inc. is NASDAQ:PMCB

    Does PharmaCyte Biotech, Inc. pay dividends?

    No, PharmaCyte Biotech, Inc. does not pay dividends

    What sector is PharmaCyte Biotech, Inc. in?

    PharmaCyte Biotech, Inc. is in the Healthcare sector

    What industry is PharmaCyte Biotech, Inc. in?

    PharmaCyte Biotech, Inc. is in the Biotechnology industry

    What country is PharmaCyte Biotech, Inc. based in?

    PharmaCyte Biotech, Inc. is headquartered in United States

    When did PharmaCyte Biotech, Inc. go public?

    PharmaCyte Biotech, Inc.'s initial public offering (IPO) was on January 2, 2013

    Is PharmaCyte Biotech, Inc. in the S&P 500?

    No, PharmaCyte Biotech, Inc. is not included in the S&P 500 index

    Is PharmaCyte Biotech, Inc. in the NASDAQ 100?

    No, PharmaCyte Biotech, Inc. is not included in the NASDAQ 100 index

    Is PharmaCyte Biotech, Inc. in the Dow Jones?

    No, PharmaCyte Biotech, Inc. is not included in the Dow Jones index

    When was PharmaCyte Biotech, Inc.'s last earnings report?

    PharmaCyte Biotech, Inc.'s most recent earnings report was on March 17, 2025

    When does PharmaCyte Biotech, Inc. report earnings?

    The next expected earnings date for PharmaCyte Biotech, Inc. is September 17, 2025
    On this page